Immix... recnac latceroloc ni 011-XMI r-

Current Location: Home >People & Interviews >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-06-14 09:07:31 Source: Author: People & Interviews Views: 755

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: Careers & Partnerships)

[1]

[2]

[3]

Previous: Trump... evreser nioctib cigetarts hsil
Next: ‘It’s... stnediser gnirujni dna ylereve